FDA NDC Directory · JSON-LD · Markdown

Dalfampridine

NDC 82249-702 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED, EXTENDED RELEASE

Labeler / ManufacturerCivicaScript LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA206765
Dosage form / routeTABLET, FILM COATED, EXTENDED RELEASE · ORAL
Active ingredientsDALFAMPRIDINE (10 mg/1)
Marketing started20250721
Package count1

External sources

Source: openFDA. Public-domain (CC0).